UBIMED, L.L.C. – Trademark Portfolio

Entity Type: 16

UBIMED, L.L.C. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include UBIMED and CLEANOZ. The owner is based in Miami, FL.

Suite 500

100 North Biscayne Boulevard

Miami, FL 33132

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CLEANOZ
CLEANOZ
Cancelled 2008
CLEANIZE
CLEANIZE
Cancelled 2008
CLEANOZ
CLEANOZ
Registered 2005
UBIMED
UBIMED
Registered 2005

Trademark Classifications

UBIMED, L.L.C.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does UBIMED, L.L.C. have?

UBIMED, L.L.C. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 cancelled.

What trademark classes does UBIMED, L.L.C. file in?

UBIMED, L.L.C. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are UBIMED, L.L.C.'s most well-known trademarks?

UBIMED, L.L.C.'s registered trademark portfolio includes well-known marks such as UBIMED and CLEANOZ. These are among 2 currently registered trademarks in the portfolio.

What is UBIMED, L.L.C.'s trademark registration success rate?

UBIMED, L.L.C. has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.